InMed To Acquire BayMedica In All-Stock Transaction Pegged At US$3.7 Million
InMed Pharmaceuticals (NASDAQ: INM) is looking to acquire one of its competitors. The firm has entered into a definitive agreement
Read moreInMed Pharmaceuticals (NASDAQ: INM) is looking to acquire one of its competitors. The firm has entered into a definitive agreement
Read moreInMed Pharmaceuticals Inc. (Nasdaq: INM) this morning announced it has entered into a securities purchase agreement with an institutional investor.
Read moreInMed Pharmaceuticals Inc. (TSX: IN) announced today that it has provided written notice to the Toronto Stock Exchange of its
Read more